People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other Technology, Other Health Care, Investment Vehicle, Manufacturing, Other Energy, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Smule, Inc. | — | Other Technology | Series C | $185.1M | $217.6M | 2011 |
| Wiland, Inc. | — | Other Technology | Series B | $34.9M | $114.5M | 2010 |
| Trusper Inc. | — | Other Technology | Series B | $24.1M | $487.9M | 2013 |
| Concordia Healthcare Inc. | — | Other Health Care | Series A | $5.1M | $102.1M | 2013 |
| Endurance Capital Self-Storage Opportunity Fund, L.P. | — | Investment Vehicle | Series A | $4.8M | $24.0M | 2024 |
| Thompson Aerospace Inc | — | Manufacturing | Seed | $2.0M | $6.1M | 2010 |
| Meridian Mining UK Societas | — | Other Energy | Pre-Seed | $1.6M | $2.5M | 2020 |
| Athlios, Inc. | — | Other Technology | Seed | $1.3M | $44.3M | 2018 |
| infiniWing, Inc. | — | Computers | Pre-Seed | $850K | $7.6M | 2011 |
Mark Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JEFF SMITH | 1 | 17 |
| GREGORY SMITH | 1 | 13 |
| Jason Pressman | 1 | 13 |
| David Chao | 1 | 11 |
| David Cowan | 1 | 11 |
| Mariana Bermudez | 1 | 6 |
| John Skinner | 1 | 6 |
| Thomas Ryan | 1 | 5 |
| Albert Lee | 1 | 4 |
| Robert Cell | 1 | 4 |
| Mark A. Thompson | 1 | 3 |
| Lei Zhang | 1 | 3 |
| Betsey Nelson | 1 | 3 |
| Standish O'Grady | 1 | 3 |
| BRUCE McLEOD | 1 | 3 |
| Stephen Polk | 1 | 2 |
| Martin McFarlane | 1 | 2 |
| Jim Wheaton | 1 | 2 |
| Ken Rudin | 1 | 2 |
| Jack Jia | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.